The Global Oral Vaccines Market Is Witnessing Strong Growth With The Launch Of Versican Plus Bb Oral Against Bordetella Bronchiseptica By Zoetis
North America is expected to dominate the global oral vaccines market and this is accredited to the increasing development of new technologies for improving vaccine efficacy in the region. For example, in August 2019, the United Nations International Children's Emergency Fund (UNICEF), reported that around 400,000 people including 65,000 children were vaccinated in a six-day oral cholera vaccination campaign run by the local health authorities of Yemen in three cities of Yemen (Aden, Al Dhale’e, and Taizz). The growing prevalence of infections such as cholera, tuberculosis, and others is driving the growth of the oral vaccine market. According to the World Health Organization (WHO), in 2019, around 1.3 million to 4.0 million cases of cholera and approximately 10 million cases of tuberculosis were reported globally in the year 2018. Additionally, rising government support towards new product approvals is again projected to drive the growth of the oral vaccines market . For insta...